Validation of the Korean Version of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease Rating Scale.
compulsive behavior
impulsive behavior
parkinson disease
rating scale
validation study
Journal
Journal of clinical neurology (Seoul, Korea)
ISSN: 1738-6586
Titre abrégé: J Clin Neurol
Pays: Korea (South)
ID NLM: 101252374
Informations de publication
Date de publication:
Apr 2020
Apr 2020
Historique:
received:
27
05
2019
revised:
26
10
2019
accepted:
28
10
2019
entrez:
23
4
2020
pubmed:
23
4
2020
medline:
23
4
2020
Statut:
ppublish
Résumé
Impulse-control disorder is an important nonmotor symptom of Parkinson's disease (PD) that can lead to financial and social problems, and be related to a poor quality of life. A nationwide multicenter prospective study was performed with the aim of validating the Korean Version of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease Rating Scale (K-QUIP-RS). The K-QUIP-RS was constructed using forward and backward translation, and pretesting of the prefinal version. PD patients on stable medical condition were recruited from 27 movement-disorder clinics. Participants were assessed using the K-QUIP-RS and evaluated for parkinsonian motor and nonmotor statuses and for PD-related quality of life using a predefined evaluation battery. The test-retest reliability of the K-QUIP-RS was assessed over an interval of 10-14 days, and correlations between the KQUIP-RS and other clinical scales were analyzed. This study enrolled 136 patients. The internal consistency of the K-QUIP-RS was indicated by a Cronbach's α coefficient of 0.846, as was the test-retest reliability by a Guttman split-half coefficient of 0.808. The total K-QUIP-RS score was positively correlated with the scores for depression and motivation items on the Unified PD Rating Scale (UPDRS), Montgomery-Asberg Depression Scale, and Rapid-Eye-Movement Sleep-Behavior-Disorders Questionnaire. The total K-QUIP-RS score was also correlated with the scores on part II of the UPDRS and the PD Quality of Life-39 questionnaire, and the dopaminergic medication dose. The K-QUIP-RS appears to be a reliable assessment tool for impulse-control and related behavioral disturbances in the Korean PD population.
Sections du résumé
BACKGROUND AND PURPOSE
OBJECTIVE
Impulse-control disorder is an important nonmotor symptom of Parkinson's disease (PD) that can lead to financial and social problems, and be related to a poor quality of life. A nationwide multicenter prospective study was performed with the aim of validating the Korean Version of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease Rating Scale (K-QUIP-RS).
METHODS
METHODS
The K-QUIP-RS was constructed using forward and backward translation, and pretesting of the prefinal version. PD patients on stable medical condition were recruited from 27 movement-disorder clinics. Participants were assessed using the K-QUIP-RS and evaluated for parkinsonian motor and nonmotor statuses and for PD-related quality of life using a predefined evaluation battery. The test-retest reliability of the K-QUIP-RS was assessed over an interval of 10-14 days, and correlations between the KQUIP-RS and other clinical scales were analyzed.
RESULTS
RESULTS
This study enrolled 136 patients. The internal consistency of the K-QUIP-RS was indicated by a Cronbach's α coefficient of 0.846, as was the test-retest reliability by a Guttman split-half coefficient of 0.808. The total K-QUIP-RS score was positively correlated with the scores for depression and motivation items on the Unified PD Rating Scale (UPDRS), Montgomery-Asberg Depression Scale, and Rapid-Eye-Movement Sleep-Behavior-Disorders Questionnaire. The total K-QUIP-RS score was also correlated with the scores on part II of the UPDRS and the PD Quality of Life-39 questionnaire, and the dopaminergic medication dose.
CONCLUSIONS
CONCLUSIONS
The K-QUIP-RS appears to be a reliable assessment tool for impulse-control and related behavioral disturbances in the Korean PD population.
Identifiants
pubmed: 32319241
pii: 16.245
doi: 10.3988/jcn.2020.16.2.245
pmc: PMC7174122
doi:
Types de publication
Journal Article
Langues
eng
Pagination
245-253Subventions
Organisme : Samil Pharm. Co., LTD
Pays : Korea
Informations de copyright
Copyright © 2020 Korean Neurological Association.
Déclaration de conflit d'intérêts
The authors have no potential conflicts of interest to disclose.
Références
Mov Disord. 2010 Nov 15;25(15):2649-53
pubmed: 21069833
J Geriatr Psychiatry Neurol. 2008 Jun;21(2):104-10
pubmed: 18474719
Neurology. 2006 Oct 10;67(7):1258-61
pubmed: 17030761
Mov Disord. 2003 Jul;18(7):738-50
pubmed: 12815652
J Parkinsons Dis. 2017;7(1):183-191
pubmed: 27911342
Arch Neurol. 2007 Feb;64(2):212-6
pubmed: 17296836
Eur J Neurol. 2015 Apr;22(4):603-9
pubmed: 25598147
Neurology. 2018 Dec 26;:
pubmed: 30587514
Mov Disord. 2007 Dec;22(16):2386-93
pubmed: 17894337
Mov Disord. 2010 May 15;25(7):867-76
pubmed: 20461804
Arch Neurol. 2010 May;67(5):589-95
pubmed: 20457959
Parkinsonism Relat Disord. 2012 Feb;18(2):155-60
pubmed: 21983019
Neurology. 2017 Jul 4;89(1):88-100
pubmed: 28592453
J Neurol Sci. 2013 Aug 15;331(1-2):76-80
pubmed: 23735774
Mov Disord. 2017 Jun;32(6):853-864
pubmed: 28467028
Neurology. 2008 Aug 26;71(9):670-6
pubmed: 18725592
J Clin Neurol. 2013 Jan;9(1):26-31
pubmed: 23346157
Neurology. 1967 May;17(5):427-42
pubmed: 6067254
Ann Neurol. 2011 Jun;69(6):986-96
pubmed: 21416496
Arch Neurol. 1993 Feb;50(2):140-8
pubmed: 8431132
Mov Disord. 2007 Mar 15;22(4):566-9
pubmed: 17260336
J Neurol. 2014 May;261(5):936-42
pubmed: 24609972
J Neurol Sci. 2015 Nov 15;358(1-2):328-32
pubmed: 26392292
Parkinsonism Relat Disord. 2019 Jun;63:117-123
pubmed: 30862454
J Neurol Neurosurg Psychiatry. 2000 Oct;69(4):566-7
pubmed: 11183044
J Neurol Neurosurg Psychiatry. 2014 Mar;85(3):311-8
pubmed: 23591553
Parkinsonism Relat Disord. 2014 Jan;20(1):22-6
pubmed: 24090948
Neurology. 2006 Oct 10;67(7):1254-7
pubmed: 16957130
Mov Disord. 2014 Feb;29(2):214-20
pubmed: 24123483
Neurology. 2013 Jan 29;80(5):496-503
pubmed: 23359374
J Neurol. 2013 Feb;260(2):429-37
pubmed: 22893307
Parkinsonism Relat Disord. 2010 Mar;16(3):202-7
pubmed: 20018549
Parkinsonism Relat Disord. 2014 Oct;20(10):1081-4
pubmed: 25085747
Mov Disord. 2006 Dec;21(12):2068-72
pubmed: 17044068
Mov Disord. 2014 Oct;29(12):1561-6
pubmed: 25164310
Arch Neurol. 2006 Jul;63(7):969-73
pubmed: 16831966
J Neurol Neurosurg Psychiatry. 2019 Jan;90(1):30-37
pubmed: 30361296
Neurology. 2016 Oct 4;87(14):1436-1441
pubmed: 27590295
Mov Disord. 2012 Jul;27(8):996-1003
pubmed: 22733427
Mov Disord. 2008 Jan;23(1):75-80
pubmed: 17960796
Mov Disord. 2009 Jul 30;24(10):1461-7
pubmed: 19452562
Mov Disord Clin Pract. 2016 Sep-Oct;3(5):494-499
pubmed: 27774496
J Neurol Neurosurg Psychiatry. 2017 Dec;88(12):1060-1064
pubmed: 29018160
Mov Disord. 2006 Aug;21(8):1265-7
pubmed: 16700027
Parkinsonism Relat Disord. 2013 Jul;19(7):698-700
pubmed: 23611687
Parkinsonism Relat Disord. 2011 Dec;17(10):761-4
pubmed: 21839665
Neurology. 2006 Jun 13;66(11):1750-2
pubmed: 16769956
Mov Disord. 2013 Mar;28(3):327-33
pubmed: 23283708
Mov Disord. 2012 Feb;27(2):242-7
pubmed: 22134954
Neurology. 2018 Jul 17;91(3):e189-e201
pubmed: 29925549
Mov Disord. 2008 Feb 15;23(3):411-5
pubmed: 18067187
Ann Indian Acad Neurol. 2015 Jan-Mar;18(1):49-59
pubmed: 25745311
Neurol Clin Pract. 2012 Dec;2(4):267-274
pubmed: 23634371
J Neurol Neurosurg Psychiatry. 2015 Feb;86(2):174-9
pubmed: 25006210
Parkinsonism Relat Disord. 2014 Aug;20(8):907-10
pubmed: 24935236